Equities

Xbrane Biopharma AB

Xbrane Biopharma AB

Actions
  • Price (EUR)0.019
  • Today's Change-0.001 / -5.00%
  • Shares traded0.00
  • 1 Year change-89.51%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Xbrane Biopharma AB (7XB:DEU) closed at 0.019, 1,800.00% above the 52 week low of 0.001 set on Sep 12, 2024.
52-week range
Today
0.001Sep 12 20240.208Feb 23 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.0168
High0.022
Low0.007
Bid0.0073
Offer0.0348
Previous close0.02
Average volume200.00
Shares outstanding1.53bn
Free float1.11bn
P/E (TTM)--
Market cap294.58m SEK
EPS (TTM)-0.7304
SEK
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.